James G Krueger

发表

Deep learning-level melanoma detection by interpretable machine learning and imaging biomarker cues

Mayte Suarez-Farinas, Josep Malvehy, James Browning, 2020, Journal of biomedical optics.

Immunology of psoriasis.

Mayte Suárez-Fariñas, James G Krueger, M. Suárez-Fariñas, 2014, Annual review of immunology.

Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis.

Mayte Suárez-Fariñas, James G Krueger, Andrea Chiricozzi, 2009, The Journal of allergy and clinical immunology.

RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications.

Mayte Suárez-Fariñas, Hui Xu, James G Krueger, 2015, The Journal of allergy and clinical immunology.

The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings.

Jennifer E Towne, James G Krueger, J. Gudjonsson, 2013, The Journal of investigative dermatology.

Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.

Luis Puig, Giampiero Girolomoni, Paul Emery, 2010, The Journal of investigative dermatology.

Potential Role of the Chemokine Receptors CXCR3, CCR4, and the Integrin αEβ7 in the Pathogenesis of Psoriasis Vulgaris

James G Krueger, J. Krueger, James B Rottman, 2001, Laboratory Investigation.

Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array.

Wing Hung Wong, Alan Menter, James G Krueger, 2003, Physiological genomics.

Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsiveness.

James G Krueger, Kathy Howell, Y. Vugmeyster, 2008, The Journal of investigative dermatology.

Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.

Mayte Suárez-Fariñas, James G Krueger, Lisa C. Zaba, 2009, The Journal of allergy and clinical immunology.

Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling

Mayte Suárez-Fariñas, Christopher T Workman, Hui Xu, 2016, The Journal of allergy and clinical immunology.

Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated.

Mayte Suárez-Fariñas, John A Carucci, James G Krueger, 2011, The Journal of investigative dermatology.

Novel Insight into the Agonistic Mechanism of Alefacept In Vivo: Differentially Expressed Genes May Serve as Biomarkers of Response in Psoriasis Patients1

James G Krueger, J. Krueger, Francesca Chamian, 2007, The Journal of Immunology.

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study.

Robert Wolk, Steven R Feldman, James G Krueger, 2016, Journal of the American Academy of Dermatology.

Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis

Mayte Suárez-Fariñas, James G Krueger, Katherine Li, 2012, The Journal of investigative dermatology.

Combining several ordinal measures in clinical studies

James G Krueger, K. Wittkowski, J. Krueger, 2004, Statistics in medicine.

A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis

Jurg Ott, Pui-Yan Kwok, Derek Gordon, 2003, Nature Genetics.

Hyperspectral imaging in automated digital dermoscopy screening for melanoma

Kristen M Kelly, Samantha Lish, Steven L Jacques, 2019, Lasers in surgery and medicine.

Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10

Wei Chen, Mark Lebwohl, James G Krueger, 2017, The Journal of Immunology.

Personalized medicine in psoriasis: developing a genomic classifier to predict histological response to Alefacept

Mayte Suárez-Fariñas, James G Krueger, M. Suárez-Fariñas, 2010, BMC dermatology.